Prevalence of adverse drug events in hospitals

“Routine data primarily recorded for reimbursement purposes are increasingly being used on a national level both in pharmacoepidemiological studies and in trigger tools. The aim of this study was to compare the prevalence rates of coded ADEs in hospitals on a transnational level.”

International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA
J Stausberg
BMC Health Services Research, 2014, 14:125

Read more here.

Evaluating adverse drug event reporting in administrative data from emergency departments

"Adverse drug events to outpatient medications were underreported in emergency department administrative data compared to the number of adverse drug events diagnosed and recorded at the point-of-care."

Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study
CM Hohl, L Kuramoto, E Yu, B Rogula, J Stausberg, B Sobolev
BMC Health Services Research, 2013, 13:473

Read more here.

Keeping patients safe when they transfer between care providers

"Improving the transfer of information about medicines across all care settings should help to reduce incidents of avoidable harm to patients, improving patient safety and contributing to a reduction in avoidable medicines related admissions and readmissions to hospital."

Keeping patients safe when they transfer between care providers - getting the medicines right
Royal Pharmaceutical Society
June 2012

Read more here.

Review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients

"We conclude that the current assessment of adverse drug events is hampered by the choice of methods."

A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients
L Hakobyan, FM Haaijer-Ruskamp, D de Zeeuw, D Dobre, P Denig
Health and Quality of Life Outcomes, 2011, 9:83

Read more here.